Form 25-NSE KalVista Pharmaceuticals Filed by: Nasdaq Stock Market LLC
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldgroup Reports Strong First Results from 26,000 Metre San Francisco Drill Program
- Consecutive Profitable Quarters in Second Half of Fiscal 2026
- Link.me and Ashton Hall Launch #ALLIN Creator Challenge
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
